Hyperbaric Oxygen Therapy
Finding Inspiration in Every Breath
Mild Hyperbaric Oxygen Therapy (HBOT) is widely recognized as a safe treatment method and is already implemented in numerous locations for the management of various medical conditions. Recent advancements in HBOT protocols have demonstrated their ability to stimulate the growth of new blood vessels and neurons in the brain. By subjecting the brain to specific pressure and oxygen fluctuations, stem cells can be activated to initiate cell division. Although HBOT is currently approved for treating decompression sickness, non-healing wounds, and radiation injury, research studies indicate its potential effectiveness in addressing various types of brain injuries, such as traumatic brain injury (TBI), post-stroke conditions, post-traumatic stress disorder (PTSD), and age-related cognitive decline.
Evidence-based Studies show
Exposure to mild hyperbaric oxygen (mHBOT), which involves increased atmospheric pressure and oxygen concentration, has the potential to enhance cellular and tissue oxidative metabolism without causing barotrauma or excessive production of reactive oxygen species. Mild hyperbaric oxygen therapy has shown promising results in inhibiting or improving metabolic syndrome and lifestyle-related diseases such as type 2 diabetes and hypertension. In recent studies we can see mHBOT also boosts the oxidative capacity of skeletal muscles in growing rats and counteracts age-related decline in mice. Furthermore, mild hyperbaric oxygen exposure has been found to inhibit the decrease of dopaminergic neurons in the substantia nigra of mice with Parkinson's disease. Overall, studies have shown highlighted the effects of mild hyperbaric oxygen therapy on various metabolic disorders and provide an optimistic outlook for its potential applications.